Evidence map›Paper›PMID 22427704›Full record

ArticleMolecular & cellular proteomics : MCP2012

Modulation of neuronal pentraxin 1 expression in rat pancreatic β-cells submitted to chronic glucotoxic stress.

Domitille Schvartz, Yohann Couté, Yannick Brunner, Claes B Wollheim, Jean-Charles Sanchez

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Bioinformatics analysis ofTranslational cancer research · 2026
    Article
  2. Article
  3. Article
  4. [Expression and Diagnostic Value of NPTX1 in Thymoma Patients].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2021
    Article
  5. Article
  6. Article
  7. The pancreatic β-cell transcriptome and integrated-omics.Current opinion in endocrinology, diabetes, and obesity · 2014
    Review
  8. Argonaute2 regulates the pancreatic β-cell secretome.Molecular & cellular proteomics : MCP · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Domitille SchvartzBiomedical Proteomics Research Group, Department of Human Protein Sciences, University Medical Center, Geneva 1211, Switzerland.
Yohann Couté
Yannick Brunner
Claes B Wollheim
Jean-Charles Sanchez
Abterra Biosciences (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin secretory granules are β-cell vesicles dedicated to insulin processing, storage, and release. The secretion of insulin secretory granule content in response to an acute increase of glucose concentration is a highly regulated process allowing normal glycemic homeostasis. Type 2 diabetes is a metabolic disease characterized by chronic hyperglycemia. The consequent prolonged glucose exposure is known to exert deleterious effects on the function of various organs, notably impairment of insulin secretion by pancreatic β-cells and induction of apoptosis. It has also been described as modifying gene and protein expression in β-cells. Therefore, we hypothesized that a modulation of insulin secretory granule protein expression induced by chronic hyperglycemia may partially explain β-cell dysfunction. To identify the potential early molecular mechanisms underlying β-cell dysfunction during chronic hyperglycemia, we performed SILAC and mass spectrometry experiments to monitor changes in the insulin secretory granule proteome from INS-1E rat insulinoma β-cells cultivated either with 11 or 30 mm of glucose for 24 h. Fourteen proteins were found to be differentially expressed between these two conditions, and several of these proteins were not described before to be present in β-cells. Among them, neuronal pentraxin 1 was only described in neurons so far. Here we investigated its expression and intracellular localization in INS-1E cells. Furthermore, its overexpression in glucotoxic conditions was confirmed at the mRNA and protein levels. According to its role in hypoxia-ischemia-induced apoptosis described in neurons, this suggests that neuronal pentraxin 1 might be a new β-cell mediator in the AKT/GSK3 apoptotic pathway. In conclusion, the modification of specific β-cell pathways such as apoptosis and oxidative stress may partially explain the impairment of insulin secretion and β-cell failure, observed after prolonged exposure to high glucose concentrations.

Indexed as

AnimalsBlotting, WesternCell Line, TumorC-Reactive ProteinGene ExpressionGene Expression ProfilingGlucoseGlycogen Synthase Kinase 3HyperglycemiaImmunohistochemistryInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansMass SpectrometryNerve Tissue ProteinsChir 99021C-Reactive ProteinGlucoseGlycogen Synthase Kinase 3InsulinNerve Tissue ProteinsPentraxinsProteomeProto-Oncogene Proteins c-aktPyridinesPyrimidines

Identifiers

PMID22427704
PMCPMC3412959
OpenAlexW2103260533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.